3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Sarcoma, Synovial
1
Sarcoma
1
Rhabdomyosarcoma
1
Recurrence
1
Medulloblastoma
1
Ependymoma
1
Brain Neoplasms
1
Interventions
Temozolomide
13
Filgrastim
8
Carboplatin
8
Radiotherapy
7
Magnetic Resonance Spectroscopy
7
Etoposide
7
Cisplatin
7
Cyclophosphamide
6
Bevacizumab
6
Vincristine
4
Thiotepa
4
Carmustine
4
sargramostim
3
Surveys and Questionnaires
3
Peripheral Blood Stem Cell Transplantation
3
Methotrexate
3
Lapatinib
3
Irinotecan
3
Azacitidine
3
veliparib
2
alovudine
2
aldesleukin
2
Tamoxifen
2
Radiotherapy, Conformal
2
Radiation
2
Paclitaxel
2
Mental Status and Dementia Tests
2
Imatinib Mesylate
2
Granulocyte-Macrophage Colony-Stimulating Factor
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Ependymoma
×
trofosfamide
×
Clear all
NCT00749723
2018-07-20
HIT-REZ-2005
University Hospital, Bonn
Phase 2/3
Completed
174 enrolled